Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEConsumer DiscretionaryAuto - PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.88 → 4.91 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for SMP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
reduce net debt leverage to 2.0x adjusted EBITDA | A supporting condition in Standard Motor Products, Inc.'s published investment case. The stated target is <=2.0x. | Under Pressure | net debt leverage remains above 2.5x at end of 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
SMP is a moderate-risk business with a recent performance-led thesis, not a proven durable compounder. Its multi-year thesis is intact, with management stable and recent results strong, but earnings quality is fragile.
The valuation signal is cheap versus peers, and the priced-in assessment says the current setup is justified rather than marked by high fragility. Valuation has eased while company momentum improved after fresh earnings, but the evidence does not establish exactly what future growth the market assumes.
Near term, the latest earnings beat and higher reported sales support momentum, and operating income also improved year over year. Management has reiterated low to mid-single digit sales growth and an 11%-12% adjusted EBITDA margin goal, but the supplied figures only partly establish delivery; net debt leverage reached 1.8x in 2026-Q3, below the stated threshold. A guidance cut would be a meaningful setback, while the near-term miss-risk assessment is quiet despite a 37% estimate and recent peer misses.
The multi-year case hinges on management sustaining sales growth and proving it can meet its adjusted margin goal, while maintaining progress on debt reduction. Near term, reaffirmed guidance would support the setup, while a cut would weaken it; earnings and guidance from GPC, BWA, and APTV may also signal whether sector support continues or fades.
Over the next 1 to 3 years, SMP’s strong recent performance and debt progress support an intact thesis, but fragile earnings quality and incomplete evidence on margin delivery leave execution as the key test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 4 of 4 supplied quarters. Management reported: “Our net debt leverage decreased to 1.8x from 2.5x in the second quarter of 2026, surpassing our target for reducing net debt levels to 2.0x adjusted EBITDA by the end of 2026.”
maintain adjusted EBITDA margin within 11%-12% | A primary condition in Standard Motor Products, Inc.'s published investment case. The stated target is 11%-12%. | Intact | adjusted EBITDA margin falls below 11% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 of 4 supplied quarters. Management reported: “Further, we reaffirm our expectation that adjusted EBITDA will be in a range of 11% -12%.” “We intend to address these pressures with our usual combination of cost savings and pricing programs.” Operating income was $50.149 million in 2026-Q3. Delivery assessment Nov 4, 2026 |
achieve low to mid-single digit revenue growth | A primary condition in Standard Motor Products, Inc.'s published investment case. The stated target is >=4% YoY. | Intact | YoY revenue growth falls below 4% in FY26 | Revenue growth: 1.8% FY2026-Q3; GAAP. Published target: >=4% YoY. Annual target cannot be compared with a quarterly or TTM observation. Oct 30, 20261.795179 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.94 → $4.91 · observed estimates
$1.94B → $1.93B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-07-25 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-07-26 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-07-27 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-07-28 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-07-29 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-07-30 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-07-31 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-08-01 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-08-02 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-08-03 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-08-04 | $4.94 | $1,937,483,670 | 3 / 3 |
| 2026-08-05 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-08-06 | $4.94 | $1,937,483,633 | 1 / 2 |
| 2026-08-08 | $4.85 | $1,936,586,000 | 3 / 3 |
| 2026-08-09 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-10 | $4.85 | $1,936,586,000 | 3 / 3 |
| 2026-08-12 | $4.88 | $1,936,252,670 | 3 / 3 |
| 2026-08-13 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-14 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-15 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-16 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-17 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-18 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-19 | $4.85 | $1,936,586,000 | 1 / 2 |
| 2026-08-20 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-21 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-22 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-23 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-24 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-25 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-26 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-27 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-28 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-29 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-30 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-08-31 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-01 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-02 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-03 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-04 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-05 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-06 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-07 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-08 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-09 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-10 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-11 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-12 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-13 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-14 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-15 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-16 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-17 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-18 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-19 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-20 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-21 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-22 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-23 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-24 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-25 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-26 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-27 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-28 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-29 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-09-30 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-01 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-02 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-03 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-04 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-05 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-06 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-07 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-08 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-09 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-10 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-11 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-12 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-13 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-14 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-15 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-16 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-17 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-18 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-19 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-20 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-21 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-22 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-23 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-24 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-25 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-26 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-27 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-28 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-29 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-30 | $4.88 | $1,936,252,667 | 1 / 2 |
| 2026-10-31 | $4.91 | $1,934,359,967 | 1 / 2 |
| 2026-11-01 | $4.91 | $1,934,359,967 | 1 / 2 |
| 2026-11-02 | $4.91 | $1,934,359,967 | 1 / 2 |
| 2026-11-03 | $4.91 | $1,932,293,333 | 1 / 2 |
| 2026-11-04 | $4.91 | $1,932,293,333 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 2 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.